In a long-term follow-up cohort study of a multicenter trial, neonatal hydrocortisone treatment in preterm infants at high risk for bronchopulmonary dysplasia showed neither benefit nor apparent harm by early school age.
These 10 states offer pediatricians the strongest mix of high earning potential, low competition, and supportive practice environments—balancing salary, demand, and quality of life for providers at any career stage.
The FDA approved Itvisma, the first gene replacement therapy for children 2 years and older, teens, and adults with spinal muscular atrophy, a one-time treatment that replaces the SMN1 gene and demonstrated improved motor function in Phase 3 studies.
Experts counter Robert F. Kennedy Jr.’s claims about aluminum adjuvant safety, noting extensive evidence that aluminum-containing vaccines remain effective and well-validated.